Mach7 Technologies

Mach7 Technologies Long-term Debt

The Long-Term Debt of Mach7 Technologies (M7T.AX) as of Nov 11, 2026 is 900,340.00 AUD. In the previous year, Long-Term Debt was 1.09 M AUD — a change of -17.17% (lower).

Long-term Debt

900,340.00AUD

YoY

-17.17%

Last updated:

Long-Term Debt of Mach7 Technologies is 2025 900,340.00 AUD. Long-Term Debt of Mach7 Technologies was 2024 1.09 M AUD. It decreases by -17.17% lower compared to the previous year.

The Mach7 Technologies Long-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Long-term Debt
Date
Long-term Debt
Jan 1, 2018
0.00 AUD
Jan 1, 2019
0.00 AUD
Jan 1, 2020
187,080.00 AUD
Jan 1, 2021
804,020.00 AUD
Jan 1, 2022
1.14 M AUD
Jan 1, 2023
991,040.00 AUD
Jan 1, 2024
1.09 M AUD
Jan 1, 2025
900,340.00 AUD
The Mach7 Technologies Long-term Debt history
YEARLong-term DebtYoY
900,340.00AUD-17.17%
1.09 MAUD+9.68%
991,040.00AUD-12.75%
1.14 MAUD+41.27%
804,020.00AUD+329.77%
187,080.00AUD—
0.00AUD—
0.00AUD-100.00%
13,010.00AUD-94.16%
222,820.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Mach7 Technologies Stock analysis

What does Mach7 Technologies do? Mach7 Technologies Ltd. generates revenue through its medical imaging software and services for healthcare institutions. The company offers the Mach7 Enterprise Imaging Solution, which includes Enterprise Data Management, Enterprise Diagnostic Viewing, and Departmental Workflow applications. Enterprise Data Management features a Vendor Neutral Archive (VNA) and data administration tools for fast storage, access, retrieval, and viewing of images across healthcare networks with cloud connectivity. Enterprise Diagnostic Viewing provides consolidated access to patient images and data for healthcare professionals, enabling timely diagnosis and treatment. The company serves global healthcare enterprises across North America, Asia Pacific, and the Middle East regions. Mach7 Technologies Ltd. targets healthcare institutions as its primary customers, including hospitals and medical facilities that require advanced imaging and data management solutions. The core products, Mach7 Enterprise Imaging Solution and its components, are sold to these institutions to streamline workflows and improve patient care. The company's focus on global healthcare enterprises ensures a broad market reach in key regions, supporting its revenue streams through software licensing and service contracts. The principal activity of Mach7 Technologies Ltd. is the development and commercialization of medical imaging and data management software solutions. The firm's offerings are designed to meet the needs of healthcare enterprises by providing integrated tools for image storage, access, and diagnostic viewing. By focusing on the North America, Asia Pacific, and Middle East regions, the company capitalizes on the growing demand for efficient healthcare data management systems, driving sales of its software solutions to healthcare institutions. Mach7 Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Mach7 Technologies stock

Long-Term Debt of Mach7 Technologies is 900,340.00 AUD in 2025.

Long-Term Debt of Mach7 Technologies changed from 1.09 M AUD to 900,340.00 AUD, representing a -17.17% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Long-Term Debt Mach7 Technologies since 2006 – with annual values, charts, and detailed analysis.

Long-term debt represents obligations due after one year. It is a key component of a company's capital structure and leverage.

Long-Term Debt's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Long-Term Debt's Mach7 Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Mach7 Technologies

All Key Metrics — Mach7 Technologies